Veno Occlusive Disease, Hepatic Withdrawn Phase 4 Trials for Sulfur hexafluoride (DB11104)

Also known as: Hepatic Veno-Occlusive Disease / Venoocclusive liver disease / Veno-occlusive disease of liver / Veno-occlusive liver disease / Veno-occlusive disease of the liver (disorder) / Venoocclusive syndrome of the liver / Sinusoidal obstruction syndrome

IndicationStatusPhase
DBCOND0105973 (Veno Occlusive Disease, Hepatic)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03963999Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant PatientsDiagnostic